AU3196200A - Beta-amino acid derivatives - Google Patents

Beta-amino acid derivatives

Info

Publication number
AU3196200A
AU3196200A AU31962/00A AU3196200A AU3196200A AU 3196200 A AU3196200 A AU 3196200A AU 31962/00 A AU31962/00 A AU 31962/00A AU 3196200 A AU3196200 A AU 3196200A AU 3196200 A AU3196200 A AU 3196200A
Authority
AU
Australia
Prior art keywords
beta
amino acid
acid derivatives
derivatives
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31962/00A
Inventor
Yoshitaka Araki
Shinichiro Hara
Fumihiko Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU3196200A publication Critical patent/AU3196200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/107—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with two aryl or substituted aryl radicals attached in positions 2 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
AU31962/00A 1999-03-26 2000-03-21 Beta-amino acid derivatives Abandoned AU3196200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8452799 1999-03-26
JP11/84527 1999-03-26
PCT/JP2000/001709 WO2000058278A1 (en) 1999-03-26 2000-03-21 β-AMINO ACID DERIVATIVES

Publications (1)

Publication Number Publication Date
AU3196200A true AU3196200A (en) 2000-10-16

Family

ID=13833123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31962/00A Abandoned AU3196200A (en) 1999-03-26 2000-03-21 Beta-amino acid derivatives

Country Status (2)

Country Link
AU (1) AU3196200A (en)
WO (1) WO2000058278A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821972B2 (en) 2001-03-30 2004-11-23 Pfizer Inc. 3-heterocyclylpropanohydroxamic acid PCP inhibitors
GB0108102D0 (en) * 2001-03-30 2001-05-23 Pfizer Ltd Compounds
EP3889142B1 (en) 2003-04-11 2022-06-15 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
US7504431B2 (en) 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
EP1969363B1 (en) * 2005-12-22 2016-11-30 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
NZ596965A (en) 2006-03-30 2013-06-28 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US8153166B2 (en) * 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
CN112979575A (en) 2014-03-06 2021-06-18 Ptc医疗公司 Pharmaceutical compositions and salts of 1,2, 4-oxadiazole benzoic acids
MX2018005361A (en) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Methods for treating epilepsy.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719621A1 (en) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarboxylic acids
KR100372138B1 (en) * 1997-08-08 2003-02-14 화이자 프로덕츠 인코포레이티드 Aryloxyarylsulfonylamino hydroxamic acid derivatives
JPH11199512A (en) * 1997-10-24 1999-07-27 Pfizer Prod Inc Use of mmp-13 selective inhibitor for the treatment of arthrosis deformans and other mmp-mediated disease
JPH11246527A (en) * 1998-03-02 1999-09-14 Shionogi & Co Ltd Mmp-8 inhibitor

Also Published As

Publication number Publication date
WO2000058278A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU1095799A (en) Folic acid derivatives
AU7556800A (en) Amine derivatives
AUPQ407699A0 (en) Aminoalcohol derivatives
AU4132000A (en) Diphenylurea derivatives
AU1433901A (en) Excitatory amino acid derivatives
HK1054038A1 (en) Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect
AU2224901A (en) Novel phenylalanine derivatives
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU5919900A (en) Cyclized amino acid derivatives
AU3677100A (en) Alpha-glycated amino acid releasing enzyme
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU3196200A (en) Beta-amino acid derivatives
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AUPQ365299A0 (en) Anthranilic acid derivatives
AU1684099A (en) Amino acid derivatives
AU1751801A (en) Protein c derivatives
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU6262300A (en) Indolinylamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase